Hematology CME

  • FEATURED
    FREE GIFT CARD

    BoardVitals Hematology and Oncology CME Pro Plus w/ Bonus $2,500 Amazon or Visa Prepaid Card

    Complete your CME and MOC Requirements Online with the BoardVitals Online CME + MOC Hematology/Oncology Self-Assessment Activity with up to a bonus $2,500 Amazon or Visa Prepaid Card. Answer board-style questions and cases related to your specialty and earn credits fast!

    Key features of BoardVitals Online CME + MOC Self-Assessment Activity include:

    • Thousands of board-style questions and cases with evidence based explanations for review
    • Aligned with the MOC / Recertification exam content for your specialty board
    • Answer questions to earn credits and correct wrong answers as you go
    • Earn up to 100 AMA PRA Category 1 CreditsTM and MOC credits (varies by specialty)
    • Up to 24-month access + a bonus $2,500 Amazon or Visa Prepaid Card (your choice.)

    Target Audience: Physicians specializing in Hematology or Oncology.

    See full details chevron_right
    • Cost: Varies
    • Credit hours: 27
    • CME credits awarded by: University of Nebraska Medical Center
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • FEATURED
    FREE GIFT CARD

    MDCalc CME With Free $2,250 Gift Card

    Maximize your CME allowance with MDCalc and get up to a $2,250 bonus gift card of your choice. Earn AMA PRA Category 1 CreditsTM for clinical content on 150+ calculators across multiple medical specialties. Easily earn and redeem CME at the point-of-care, online on our website or mobile app. Over 1 million medical professionals use MDCalc’s 550+ tools daily to support clinical decision making at the bedside.

    See full details chevron_right
    • Cost: Varies
    • Credit hours: Unlimited
    • CME credits awarded by: EBMedicine
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • FEATURED

    BoardVitals Hematology and Oncology CME Board Review

    The BoardVitals Hematology and Oncology CME Review offers clinicians 27 AMA PRA Category 1 CreditsTM, 27 ABIM MOC points, and over 500 Hematology and Oncology board review questions. The questions cover key topics including Breast Cancer, Gynecologic Cancer, and Transfusion Medicine. This question bank will assist clinicians with Hematology and Oncology certification and recertification.

    The BoardVitals Hematology and Oncology CME Review also features:

    • Quick and Convenient CME
    • Computer, phone, and tablet access
    • Constantly updated up-to-date questions
    • Questions that are targeted specifically to the exam
    • Online CME tracker
    • 100% Pass Guarantee
    • Statistical comparison to other Hematology and Oncology test-takers (Nationally)

     

    After completing this activity, you should be able to:

    • Make a diagnosis
    • Order and interpret results
    • Assess risk, determine prognosis, and apply principles from epidemiologic studies
    • Describe the underlying pathophysiology of disease and basic science knowledge

     

    Target Audience: Hematologists and Oncologists

    See full details chevron_right
    • Cost: $599
    • Credit hours: 27
    • CME credits awarded by: BoardVitals
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • 30% OFF W/ CODE: CME30

    Oakstone CME Brigham and Dana-Farber Board Review in Hematology and Oncology

    Learn Now CME: Advances in Hematology and Oncology

    The Brigham and Dana-Farber Board Review in Hematology and Oncology CME will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this online CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

    • Perform differential diagnosis of complex hematologic and oncologic disorders
    • Identify and apply current therapeutic options for hematologic and oncologic disorders
    • Evaluate and interpret up-to-date literature relevant to hematology and oncology
    • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
    • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

    Learning Objectives

    Upon completion of this activity, the participant will be able to:

    • Apply current/recommended Hematology and Oncology guidelines in clinical practice
    • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
    • Identify/apply current therapeutic options for specific Hematologic and Oncologic disorders
    • Review and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
    • Demonstrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
    • Apply knowledge gained to the ABIM Certification/Recertification Hematology and Oncology examinations

    Intended Audience

    The activity was planned for fellows/trainees, practicing Hematology and Oncology specialists (MDs), and other professional affiliates (internists with an interest in Hematology and Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology and Oncology Medicine.

    See full details chevron_right
    • Cost: $1795
    • Credit hours: 44
    • CME credits awarded by: Oakstone Publishing, LLC.
    • Format: Online, On Demand, USB
    • Material last updated: April 15, 2020
    • Expiration of CME credit: April 15, 2023
  • 30% OFF W/ CODE: CME30

    Oakstone CME Brigham and Dana-Farber Board Review in Hematology

    Elevate Your Hematology CME

    The Brigham and Dana-Farber Board Review in Hematology online CME program brings together a distinguished group of experts to present current diagnostic and therapeutic strategies. Enhanced patient care and prepare for boards with topics like molecular genetics, leukemia, bone marrow failures, transfusion medicine and more. It’s continuing medical education that will help you to better:

    • Apply current/recommended hematology guidelines in clinical practice
    • Perform differential diagnosis of complex hematologic disorders
    • Identify and apply current therapeutic options for hematologic disorders
    • Evaluate and interpret up-to-date literature relevant to clinical practice in hematology
    • Illustrate knowledge of pathophysiology of hematology disorders
    • Apply knowledge gained to the ABIM certification/recertification

    Learning Objectives

    At the conclusion of this activity, the participant will be able to:

    • Apply current/recommended Hematology guidelines in clinical practice
    • Perform differential diagnosis of complex clinical presentations related to Hematologic disorders
    • Identify/apply current therapeutic options for specific Hematologic disorders
    • Review and interpret up-to-date literature relevant to clinical practice in Hematology
    • Demonstrate knowledge of pathophysiology as it applies to management of Hematology disorders
    • Apply knowledge gained to the ABIM Certification/Recertification Hematology and Oncology examinations

    Intended Audience

    The activity was planned for fellows/trainees, practicing Hematology specialists (MDs), and other professional affiliates (internists with an interest in Hematology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology Medicine.

    See full details chevron_right
    • Cost: $1295
    • Credit hours: 25.25
    • CME credits awarded by: Oakstone Publishing, LLC
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: April 15, 2020
    • Expiration of CME credit: April 15, 2023
  • MedCram 3 year All Access CME Pass

    Medical videos & lectures explained clearly by world-class instructors.

    Memorable illustrations, clinical scenarios, and passionate instructors set MedCram apart from other online medical lectures.

    We prioritize the most important clinically relevant and practical information for clinical practice.

    Understanding medicine has never been so simplified.

    See full details chevron_right
    • Cost: $495
    • Credit hours: 46.75
    • CME credits awarded by: ACCME
    • Format: Medical education videos available on demand
    • Material last updated: Continuously Updated
  • FREE

    CME: von Willebrand’s Disease (vWB): Therapeutic Updates and Optimizing Treatment

    In this online, self-learning activity:

    Von Willebrand disease (vWD) is the most common congenital bleeding disorder worldwide. Affecting both male and female births in equal number, vWD is caused by a deficiency or defect in the von Willebrand factor (vWF) glycoprotein, which is responsible for mediating platelet and coagulation factor VIII function. vWD types 1 and 3 are caused by quantitative deficiencies in vWF. In contrast, type 2 vWD is caused by a qualitative defect in the production of vWF. Type 1 is the most common type of vWD, accounting for 60% to 70% of cases, followed by type 2, which is diagnosed in 25% to 30% of patients. Type 3 vWD, the rarest form, affects about 1 in 1,000,000 people. There is evidence that the use of factor VIII/vWF concentrates should be individualized, but no recent vWD guidelines address this issue. Although DDAVP is the treatment of choice for most type 1 vWD patients, data do not support the use of DDAVP for type 2B vWD owing in part to an increased risk for thrombocytopenia. Another practice gap is a lack of guidance around the appropriate ages at which patients with severe vWD are optimally initiated on vWF prophylaxis. Furthermore, although DDAVP is not contraindicated in pregnancy, 31% of physicians consider DDAVP a contraindication according to the results of one survey, illustrating a present area of controversy in practice.

    Target Audience:

    The following healthcare professionals: Hematologists and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in hematology; and any other healthcare professionals with an interest in or who clinically encounter patients with vWD.

    See full details chevron_right
    • Cost: Free
    • CME credits awarded by: 1
    • Format: On-Demand Online
    • Material last updated: March 07, 2021
    • Expiration of CME credit: March 07, 2023
  • FREE

    Update on Therapeutic Advances in T-Cell Lymphoma

    Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based live webinar series! Register today!

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: i3 Health
    • Format: Webinar
  • FREE

    Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes

    In this virtual tumor board, David P. Steensma, MD, FACP, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C, discuss patient and tumor characteristics that inform personalized care plans, risk stratification, and supportive care strategies for patients with MDS.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: i3 Health in partnership with Anaplastic Anemia & Myelodysplastic Syndromes International Foundation
    • Format: Online, On Demand
  • FREE

    Treating Oncology Patients During COVID-19

    Activity Description / Statement of Need: The COVID-19 pandemic has led to unprecedented changes in health care delivery worldwide, affecting the way that nearly every medical specialty can safely practice. As with other fields of medicine, oncology has its own challenges in navigating the pandemic. Based on pre-pandemic estimates, 1.8 million new cancer diagnoses would be expected in 2020, equating to approximately 5,000 new cancer diagnoses per day. Evidence thus far suggests that COVID-19 is associated with significantly more complications and a higher risk of death in patients with cancer or with a history of cancer. Furthermore, patients with cancer have also been shown to have a higher COVID-19 infection rate than the general population, suggesting increased susceptibility, potentially due to immunosuppression, comorbidities, or poor health status related to cancer or its treatment. Based on these data, oncology specialists are said to be fighting “a war on two fronts” by balancing the risks of COVID-19 transmission and acquisition with the risks of delayed cancer diagnosis and treatment. This represents an unmet need among oncology practitioners as they navigate this new health care landscape.

    Target Audience:

    Healthcare professionals, including medical oncologists; radiation oncologists; surgical oncologists; surgeons; radiologists; nuclear medicine specialists; nurse practitioners and physician assistants who practice in oncology; and other healthcare providers who manage cancer.

    By the end of the session the participant will be able to:

    • Recall the symptoms of COVID-19 infection and best practices for screening patients, health care providers, and staff in the oncology setting.
    • Develop a plan to provide oncology care in the setting of the COVID-19 pandemic.
    • Describe the risks of delaying cancer diagnosis and treatment against the risk of COVID-19 exposure and infection.
    • See full details chevron_right
    • Cost: Free
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 09/22/2020
    • Expiration of CME credit: 09/22/2022